公开(公告)号：US20120076875A1

公开(公告)日：2012-03-29

申请号：US12929144

申请日：2011-01-04

Applicant: Chen-Yu Lee ,  Hsiu-Chin Ho ,  Cheng-Fu Chang ,  Yi Lin Chen

Inventor： Chen-Yu Lee ,  Hsiu-Chin Ho ,  Cheng-Fu Chang ,  Yi Lin Chen

IPC: A61K36/258 ,  A61P25/00

CPC classification number: A61K36/258 ,  A61K36/714

Abstract: A herbal medicinal composition and an extract thereof for inducing proliferation of cranial nerve cells and a method of manufacturing the same are disclosed. The herbal medicinal composition includes Ginseng Radix and Aconiti Tuber.

Abstract translation: 公开了一种用于诱导颅神经细胞增殖的草药组合物及其提取物及其制造方法。 草药组合物包括人参和芦荟块茎。

公开(公告)号：US20110142963A1

公开(公告)日：2011-06-16

申请号：US12923846

申请日：2010-10-12

Applicant: Chen-Yu Lee

Inventor： Chen-Yu Lee

IPC: A61K36/539 ,  A61K36/515 ,  A61K36/284 ,  A61K36/484 ,  A61K33/04 ,  A61K36/65 ,  A61K36/236 ,  A61K36/815 ,  A61K36/46 ,  A61K36/8945 ,  A61K36/54 ,  A61K36/9068 ,  A61K36/725 ,  A61K36/71 ,  A61P35/00

CPC classification number: A61K36/71 ,  A61K33/04 ,  A61K36/185 ,  A61K36/232 ,  A61K36/236 ,  A61K36/28 ,  A61K36/284 ,  A61K36/46 ,  A61K36/484 ,  A61K36/515 ,  A61K36/539 ,  A61K36/54 ,  A61K36/64 ,  A61K36/65 ,  A61K36/725 ,  A61K36/804 ,  A61K36/815 ,  A61K36/8945 ,  A61K36/9068 ,  A61K2300/00

Abstract: The present invention relates to herbal medicinal compositions and extracts thereof for inhibiting growth of cancer cells. One of the examples described in the present invention comprises Forsythiae fructus, Menthae Herba, Gardeniae Fructus, Scutellariae Radix, Lophatheri Folium, Glycyrrhizae Radix, Rhei Rhizoma, Na2SO4, and Atractylodis Rhizoma. The residual examples are described herein.

Abstract translation: 本发明涉及用于抑制癌细胞生长的草药组合物及其提取物。 本发明中描述的一个实例包括连翘，薄荷草，栀子，黄芩，枸杞，甘草，枸杞子，Na 2 SO 4，和Atractylodis Rhizoma。 这里描述了残留实施例。

公开(公告)号：US20230141424A1

公开(公告)日：2023-05-11

申请号：US17520856

申请日：2021-11-08

Applicant: Ying-Chieh HUANG ,  Chen-Yu LEE

Inventor： Ying-Chieh HUANG ,  Chen-Yu LEE

IPC: A61K36/8969 ,  A61K36/258 ,  A61K36/79 ,  A61K36/725 ,  A61K36/40 ,  A61K36/70 ,  A61K36/537 ,  A61K36/484 ,  A61K45/06

CPC classification number: A61K36/8969 ,  A61K36/258 ,  A61K36/79 ,  A61K36/725 ,  A61K36/40 ,  A61K36/70 ,  A61K36/537 ,  A61K36/484 ,  A61K45/06

Abstract: The present invention relates to a method for treating HIV/AIDS complications including administering a first Chinese herbal medicine composition to a subject in need; wherein the first Chinese herbal medicine composition is an extract of a first mixture including Polygonatum sibiricum, Astragalus membranaceus, Panax ginseng, Liriope spicata, Schisandra chinensis, Ziziphus zizyphus, Cornus officinalis, Fallopia multiflora, and Salvia miltiorrhiza.

公开(公告)号：US20220143127A1

公开(公告)日：2022-05-12

申请号：US17090931

申请日：2020-11-06

Applicant: Chen-Yu LEE

Inventor： Chen-Yu LEE ,  Yi-De KUO ,  Hsuan-Ching TSENG ,  Yan-Chih LIAO ,  Luan-Yao CHIEN ,  Kun-Cheng LIN ,  Wei-Te CHENG

IPC: A61K36/9068 ,  A61K36/61 ,  A61K36/65 ,  A61K36/31 ,  A61K36/539 ,  A61K36/725 ,  A61K47/02 ,  A61K36/718 ,  A61K36/88 ,  A61K36/185 ,  A61K36/736 ,  A61K35/02 ,  A61K36/884 ,  A61K36/284 ,  A61K9/00 ,  A61P17/06

Abstract: The present invention relates to a method for treating psoriasis including: administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture including Pimenta officinalis, Paeonia veitchii, Anastatica hierochuntica, Zingiber officinale, Scutellaria baicalensis, and Ziziphus jujube.

公开(公告)号：US10471117B2

公开(公告)日：2019-11-12

申请号：US15855252

申请日：2017-12-27

Applicant: Chen-Yu Lee

Inventor： Chen-Yu Lee

IPC: A61K36/00 ,  A61K36/9068 ,  A61K36/428 ,  A61K36/40 ,  A61K36/64 ,  A61K36/8945 ,  A61K36/232 ,  A61K36/46 ,  A61K36/39 ,  A61K36/815 ,  A61K36/54 ,  A61K36/714 ,  A61K36/076 ,  A61K36/756 ,  A61K36/21 ,  A61K36/284 ,  A61K36/258 ,  A61K35/32 ,  A61K33/06 ,  A61K36/708 ,  A61P13/12

Abstract: The present invention is directed to a therapeutic method of treatment of uremia associated with renal dysfunction long after transplant, comprising administering to a subject in need a therapeutically effective amount of a Chinese medicine composition. The Chinese medicine composition is the extract of the mixture including Fructus corni, radix Rehmanniae, rhizoma Dioscoreae, Radix Angelica sinensis, Cortex eucommiae, Semen cuscutae, Fructus lycii, Fructus Cinnamomum cassia, Radix aconiti lateralis preparata, Rhizoma Zingiberis, Poria, Phelloendron amurense Cortex, radix Achyranthis Bidentatae, and Atractylodes Lancea Rhizoma.

公开(公告)号：US10322157B2

公开(公告)日：2019-06-18

申请号：US15642570

申请日：2017-07-06

Applicant: Chen-Yu Lee

Inventor： Chen-Yu Lee ,  Yan-Chih Liao

IPC: A61K35/618 ,  A61K36/8945 ,  A61K35/32 ,  A61K33/26 ,  A61K36/21 ,  A61K36/65 ,  A61K36/64 ,  A61K36/14 ,  A61K36/076 ,  A61K36/884 ,  A61K36/8988 ,  A61K36/17 ,  A61K36/708 ,  A61K36/126 ,  A61K33/06 ,  A61K36/258 ,  A61K36/718 ,  A61K36/605 ,  A61K36/31 ,  A61K36/804 ,  A61K33/00

Abstract: The present invention is directed to a therapeutic method of treatment of diabetes mellitus, particularly diabetes which acquires multiple drug resistance, comprising administering a therapeutically effective amount of Chinese herbal medicine to a subject in need. The Chinese herbal medicine is the decocting extract including the mixture of raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, and semen Platycladi.

公开(公告)号：US10314876B2

公开(公告)日：2019-06-11

申请号：US15642561

申请日：2017-07-06

Applicant: Chen-Yu Lee

Inventor： Chen-Yu Lee ,  Yan-Chih Liao

IPC: A61K35/618 ,  A61K36/8945 ,  A61K35/32 ,  A61K33/26 ,  A61K36/21 ,  A61K36/65 ,  A61K36/64 ,  A61K36/14 ,  A61K36/718 ,  A61K36/605 ,  A61K36/708 ,  A61K36/12 ,  A61K36/35 ,  A61K36/804 ,  A61K36/11

Abstract: A therapeutic method for treating diabetes mellitus, particularly diabetes caused by pancreatitis, comprising administering an effective amount of a Chinese herbal medicine to a subject. The Chinese herbal medicine is an extract of a mixture comprising specific amount of raw oyster shell powder, raw Os Draconis, Haematitum (Hematite), Magnetitum (Magnetite), radix Achyranthis Bidentatae (Achyranthes bidentata), rhizoma Dioscoreae (Dioscoreae Rhizoma), radix Paeoniae Rubra (Paeoniae Radix Rubra), radix Rehmanniae (Rehmannia), semen Platycladi (Platycladi Semen), Coptidis Rhizoma, cortex Mori, rhubarb (Rhei Radix et Rhizoma), and Davallia formosana (Davallia formosana Hay.).

公开(公告)号：US20190008916A1

公开(公告)日：2019-01-10

申请号：US15642570

申请日：2017-07-06

Applicant: Chen-Yu LEE

Inventor： Chen-Yu LEE ,  Yan-Chih LIAO

IPC: A61K36/8945 ,  A61K35/618 ,  A61K35/32 ,  A61K33/26 ,  A61K36/21 ,  A61K36/65 ,  A61K36/64 ,  A61K36/14 ,  A61K36/076 ,  A61K36/884 ,  A61K36/8988 ,  A61K36/17 ,  A61K36/708 ,  A61K36/126 ,  A61K33/06 ,  A61K36/258 ,  A61K36/718 ,  A61K36/605 ,  A61K36/31

Abstract: The present invention is directed to a therapeutic method of treatment of diabetes mellitus, particularly diabetes which acquires multiple drug resistance, comprising administering a therapeutically effective amount of Chinese herbal medicine to a subject in need. The Chinese herbal medicine is the decocting extract including the mixture of raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, and semen Platycladi.

公开(公告)号：US09192642B1

公开(公告)日：2015-11-24

申请号：US14281976

申请日：2014-05-20

Applicant: Chen-Yu Lee

Inventor： Chen-Yu Lee ,  Da-Tong Ju ,  Hsing-Lung Chao ,  Shih-Fang Chung ,  Hsin-I Ma ,  Yee-Min Jen

IPC: A01N65/00 ,  A61K36/8888 ,  A61K36/233 ,  A61K36/539 ,  A61K36/65 ,  A61K36/708 ,  A61K36/752 ,  A61K36/725 ,  A61K36/06 ,  A61K36/884 ,  A61K36/284 ,  A61K36/13 ,  A61K36/537 ,  A61K36/236 ,  A61K36/8988 ,  A61K36/258 ,  A61K36/00

CPC classification number: A61K36/725 ,  A61K36/00 ,  A61K36/06 ,  A61K36/13 ,  A61K36/233 ,  A61K36/236 ,  A61K36/258 ,  A61K36/284 ,  A61K36/537 ,  A61K36/539 ,  A61K36/65 ,  A61K36/708 ,  A61K36/752 ,  A61K36/884 ,  A61K36/8888 ,  A61K36/8988 ,  A61K2300/00

Abstract: A method for reducing liver and kidney damage caused by radiotherapy is disclosed. The method comprises administering a herbal medicinal composition to a subject in need, wherein the herbal medicinal composition comprises 1.3-5.3 parts by weight of Chaihu, 2.2-8.8 parts by weight of Hunagqing, 1.8-7.0 parts by weight of Panxia, 1.8-7.0 parts by weight of Chishaoyao, 0.5-1.8 parts by weight of Dahuang, 1.3-5.3 parts by weight of Zhishi, 2.2-8.8 parts by weight of Hungtsao, 4.4-17.5 parts by weight of Fuling, 1.8-7.0 parts by weight of Chuling, 2.2-8.8 parts by weight of Zerxie, 1.8-7.0 parts by weight of Changchu, 1.3-5.3 parts by weight of Mahuang, 1.8-7.0 parts by weight of Dansheng, 2.2-8.8 parts by weight of Chuanxiong, 2.2-8.8 parts by weight of Wuchuyu, 2.2-8.8 parts by weight of Tienma, 1.3-5.3 parts by weight of Ginseng, and 1.3-5.3 parts by weight of Chuanchi.

Abstract translation: 公开了一种降低放射治疗引起的肝肾损伤的方法。 该方法包括向需要的受试者施用草药组合物，其中所述草药组合物包含柴胡1.3-5.3重量份，Hun格青2.2-8.8重量份，潘夏1.8-7.0重量份，1.8-7.0重量份 柴达奥重量份，大黄0.5-1.8重量份，志氏1.3-5.3重量份，红枣2.2-8.8重量份，F陵4.4-17.5重量份，ul陵1.8-7.0重量份 ，Zerxie 2.2-8.8重量份，Changchu 1.8-7.0重量份，Mahuang 1.3-5.3重量份，Dansheng 1.8-7.0重量份，Chuanxiong 2.2-8.8重量份，2.2-8.8重量份 的武修玉，天津2.2-8.8重量份，人参1.3-5.3重量份，川崎1.3-5.3重量份。

公开(公告)号：US08668940B2

公开(公告)日：2014-03-11

申请号：US13873828

申请日：2013-04-30

Applicant: Chen-Yu Lee

Inventor： Chen-Yu Lee

IPC: A61K36/00 ,  A61K36/65 ,  A61K36/804 ,  A61K36/539

CPC classification number: A61K36/71 ,  A61K33/04 ,  A61K36/185 ,  A61K36/232 ,  A61K36/236 ,  A61K36/28 ,  A61K36/284 ,  A61K36/46 ,  A61K36/484 ,  A61K36/515 ,  A61K36/539 ,  A61K36/54 ,  A61K36/64 ,  A61K36/65 ,  A61K36/725 ,  A61K36/804 ,  A61K36/815 ,  A61K36/8945 ,  A61K36/9068 ,  A61K2300/00

Abstract: The present invention relates to herbal medicinal compositions and extracts thereof for inhibiting growth of cancer cells. One of the examples described in the present invention comprises Forsythiae fructus, Menthae Herba, Gardeniae Fructus, Scutellariae Radix, Lophatheri Folium, Glycyrrhizae Radix, Rhei Rhizoma, Na2SO4, and Atractylodis Rhizoma. The residual examples are described herein.

Abstract translation: 本发明涉及用于抑制癌细胞生长的草药组合物及其提取物。 本发明中描述的一个实例包括连翘，薄荷草，栀子，黄芩，枸杞，甘草，枸杞子，Na 2 SO 4，和Atractylodis Rhizoma。 这里描述了残留实施例。